Trigeminal autonomic cephalalgias (TACs)
Headache overview · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Management
- A family of primary headaches with strictly UNILATERAL pain in the trigeminal (usually first-division) distribution PLUS prominent IPSILATERAL cranial autonomic features (lacrimation, conjunctival injection, nasal congestion/rhinorrhoea, ptosis/miosis, eyelid oedema)
- Distinguish the members by attack duration and frequency: cluster (15–180 min, up to 8/day), paroxysmal hemicrania (2–30 min, >5/day), SUNCT/SUNA (seconds, up to 200/day), hemicrania continua (continuous with exacerbations)
- Treatment differs by type: cluster → high-flow oxygen + subcutaneous/nasal triptan (acute), verapamil (prevention)
- Paroxysmal hemicrania AND hemicrania continua → ABSOLUTE response to indometacin (both diagnostic and therapeutic)
- SUNCT/SUNA → lamotrigine (poorly responsive to acute drugs)
- ALL new TACs need MRI brain (± pituitary) to exclude a secondary/symptomatic cause
Drugs & doses
High-flow oxygen + SC/nasal triptan (cluster)
Indometacin (paroxysmal hemicrania / hemicrania continua)
Verapamil (cluster prevention)
Lamotrigine (SUNCT/SUNA)
Disposition
Neurology referral; MRI brain. Cluster attacks can be aborted in the ED with oxygen + triptan.
An indometacin trial is the key diagnostic step — paroxysmal hemicrania and hemicrania continua respond completely, the others do not. Restlessness/agitation during attacks (unlike migraine, where patients keep still) is characteristic of TACs.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.